Lejian Biotech Peptide
Retatrutide
Finnrick tested 1 sample of Retatrutide (GLP-1, GIP, and GCGR agonist) from Lejian Biotech Peptide on 19 May 2026. With fewer than 2 tests, a Finnrick rating of X (Unrated) was awarded.
Finnrick Rating™
Lejian Biotech Peptide
Retatrutide
Tested 1 Sample
Last test 19 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Lejian Biotech Peptide
Samples are tested in commercial labs
Tests Count
1
Scores
AVGMINMAX
Last
19 May 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 19 May 2026 | View | 10mg | 10.2mg | +2.0% | 99.90% | low | 258013 | No Label / Silver Crimp / White Cap | Lab E | Public | |